SHE Collaborates receives funding for projects in Jemen and South-Sudan
SHE Collaborates will receive €225,000 from Nuffic for three projects in Jemen and South-Sudan. UM will help teachers in Maridi (Sudan) create and run a training programme for their students. Those students will then give water and hygiene trainings to volunteers in their communities. The workshops will take place in Kenia, because it’s not safe enough in Sudan. SHE Collaborates is running this project in collaboration with Amref International University in Nairobi and Amref Flying Doctors in Leiden.
Jemen
Additionally, there will be funding for Aden University’s medical faculty (Jemen). Using Google Hangouts, the university’s students will get online instructions from Maastricht in new education techniques, primarily on the field of Water, Sanitation and Hygiene (WASH). This is very important given the water shortage in Jemen. UM is working together with a partner in Jemen. The third project entails a refresher course for nurses in Jemen, which will also be given remotely.
Collaboration
€75,000 are reserved for each yearlong project. “Collaboration is important since we sometimes don’t have enough expertise to transfer our knowledge and make it relevant in a different context. It’s more effective to involve local or regional partners. There is an extra advantage in this case, because our local partners have fewer travel restrictions”, says Geraldine Beaujean, managing director of SHE Collaborates.
Also read
-
In honour of the presentation of the VNVA Els Borst Prize for her oeuvre, Prof Marlies Bongers is organising the symposium "menstruation in RED on the agenda" on 1 October.
-
In women trying to conceive, 1-3% experience repeated miscarriages. For more than 50% of these women, a cause for the miscarriages has yet to be found. New research from Maastricht University (UM) and the Maastricht University Medical Centre+ (MUMC+) shows that the immune system’s Natural Killer (NK) cells may be involved. In women with repeated miscarriages, the NK cells have different characteristics.
-
The European Commission has awarded €23 million to set up a new platform for drug repurposing: the use of existing drugs in diseases other than those for which they were originally developed. In the next seven years UM will develop the platform REPO4EU (precision drug REPurpOsing for Europe) together with various international partners. A congress in Maastricht held on 2-3 September kicked off the project.
